摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Hydroxy-3,4-dihydro-2H-1,4-benzoxazin | 70801-40-0

中文名称
——
中文别名
——
英文名称
2-Hydroxy-3,4-dihydro-2H-1,4-benzoxazin
英文别名
3,4-dihydro-2H-1,4-benzoxazin-2-ol
2-Hydroxy-3,4-dihydro-2H-1,4-benzoxazin化学式
CAS
70801-40-0
化学式
C8H9NO2
mdl
MFCD18814204
分子量
151.165
InChiKey
SWSZCVQLIXXYJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    323.0±42.0 °C(Predicted)
  • 密度:
    1.256±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    41.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOSITION FOR OXIDATION DYEING OF HUMAN KERATIN FIBRES AT A PH OF LESS THAN 8, COMPRISING A FATTY ALCOHOL, A FATTY ESTER AND A CATIONIC SURFACTANT, METHOD USING SAME AND DEVICE
    申请人:Debain Jean-Daniel
    公开号:US20100313361A1
    公开(公告)日:2010-12-16
    The present invention relates to a dyeing composition for the oxidative dyeing of human keratin fibres, at a pH less than 8, comprising one or more oxidative dye precursors, one or more fatty alcohols and fatty esters as well as one or more cationic surfactants, the weight ratio of fatty alcohol(s) to fatty acid ester(s) being greater than 2 and less than 10. It also relates to a ready-to-use composition obtained by extemporaneous mixing with an oxidizing composition prior to using the aforementioned dyeing composition. It also relates to a method of colouring keratin fibres in which the ready-to-use composition is applied on said fibres. According to another variant of the method of colouring, the aforementioned dyeing composition and the oxidizing composition are applied successively and without intermediate rinsing. The invention also relates to a device with several compartments that are suitable for its application.
    本发明涉及一种用于在pH小于8的条件下氧化染人类角蛋白纤维的染料组合物,包括一种或多种氧化染料前体、一种或多种脂肪醇脂肪酸酯以及一种或多种阳离子表面活性剂脂肪醇脂肪酸酯的重量比大于2且小于10。本发明还涉及一种通过即时混合含氧化剂的组合物获得的即用型组合物,用于在染色组合物中使用前。本发明还涉及一种染色角蛋白纤维的方法,其中将即用型组合物应用于所述纤维上。根据另一种染色方法的变体,上述染料组合物和氧化剂组合物被连续应用而无需中间冲洗。本发明还涉及一种适用于其应用的具有多个隔室的装置。
  • Linkage of agents using microparticles
    申请人:Green Howard
    公开号:US20060110379A1
    公开(公告)日:2006-05-25
    Methods, products and kits are provided for attaching agents to a skin surface via microparticles using endogenous or exogenous transglutaminase.
    提供了一种方法、产品和套件,可通过内源或外源性谷酰胺转移酶使用微粒子将药剂附着到皮肤表面。
  • EMULSION DYEING COMPOSITION CONTAINING AT LEAST ONE POLYAMINE, AT LEAST ONE NONIONIC SURFACTANT AND AT LEAST ONE PHOSPHATE ESTER, AND METHOD OF USING SAME
    申请人:HASHIMOTO Sawa
    公开号:US20120325241A1
    公开(公告)日:2012-12-27
    The present invention is drawn to a composition and method for dyeing keratinous substrates containing: (a) at least one polyamine compound having at least three amino groups; (b) at least one nonionic surfactant; (c) at least one phosphate ester chosen from alkoxylated alkyl phosphate esters and alkyl phosphate esters; (d) at least one dye chosen from oxidation dye precursors and direct dyes. The compositions of the present invention may optionally contain at least one thickening agent, at least one alkaline agent, at least one fatty substance, at least one salt, and at least one oxidizing agent.
    本发明涉及一种含有以下成分的染色角蛋白质基质的染料组合物和方法:(a)至少一种具有至少三个基团的聚胺化合物;(b)至少一种非离子表面活性剂;(c)至少一种磷酸酯,选择自烷氧基化烷基磷酸酯和烷基磷酸酯;(d)至少一种选择自氧化染料前体和直接染料染料。本发明的组合物可以选择性地包含至少一种增稠剂,至少一种碱性剂,至少一种脂肪物质,至少一种盐和至少一种氧化剂。
  • EMULSION DYEING COMPOSITION CONTAINING AT LEAST ONE POLYAMINE, AT LEAST ONE NONIONIC SURFACTANT AND AT LEAST ONE CARBOXYLIC ACID, AND METHOD OF USING SAME
    申请人:HASHIMOTO Sawa
    公开号:US20120325259A1
    公开(公告)日:2012-12-27
    The present invention is drawn to a composition and method for dyeing keratinous substrates containing: (a) at least one polyamine compound comprising at least three amino groups; (b) at least one nonionic surfactant; (c) at least one compound chosen from an alkyl ether carboxylic acid, an alkyl ether carboxylate, a fatty acid having from about 6 to about 40 carbon atoms, and mixtures thereof; (d) at least one dye chosen from oxidation dye precursors and direct dyes. The compositions of the present invention may optionally contain at least one thickening agent, at least one alkaline agent, at least one fatty substance, at least one salt, and at least one oxidizing agent.
    本发明涉及一种用于染色角蛋白基质的组合物和方法,包含:(a)至少一种含有至少三个基的多胺化合物;(b)至少一种非离子表面活性剂;(c)至少一种从大约6到大约40个碳原子的脂肪酸中选择的烷基醚羧酸,烷基醚羧酸盐,脂肪酸,以及它们的混合物;(d)至少一种从氧化染料前体和直接染料中选择的染料。本发明的组合物可以选择性地包含至少一种增稠剂,至少一种碱性剂,至少一种脂质物质,至少一种盐,以及至少一种氧化剂。
  • EMULSION DYEING COMPOSITION CONTAINING AT LEAST ONE PHOSPHOLIPID, AT LEAST ONE NONIONIC SURFACTANT AND AT LEAST ONE CARBOXYLIC ACID, AND METHOD OF USING SAME
    申请人:HASHIMOTO Sawa
    公开号:US20120325260A1
    公开(公告)日:2012-12-27
    The present invention is drawn to a composition and method for dyeing keratinous substrates containing: (a) at least one phospholipid; (b) at least one nonionic surfactant; (c) at least one compound chosen from an alkyl ether carboxylic acid, an alkyl ether carboxylate, a fatty acid having from about 6 to about 40 carbon atoms, and mixtures thereof; (d) at least one dye chosen from oxidation dye precursors and direct dyes. The compositions of the present invention may optionally contain at least one thickening agent, at least one alkaline agent, at least one fatty substance other than a fatty acid, at least one salt, and at least one oxidizing agent.
    本发明涉及一种染色角质蛋白基质的组合物和方法,其包含:(a)至少一种磷脂类物质;(b)至少一种非离子表面活性剂;(c)至少一种从具有约6到约40个碳原子的脂肪酸,烷基醚羧酸盐,烷基醚羧酸或其混合物中选择的化合物;(d)至少一种从氧化染料前体和直接染料中选择的染料。本发明的组合物可以选择地包含至少一种增稠剂,至少一种碱性剂,至少一种除脂肪酸外的脂质物质,至少一种盐和至少一种氧化剂。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)